These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 37576862)

  • 1. Cancer stem cells in brain tumors: From origin to clinical implications.
    Lin S; Li K; Qi L
    MedComm (2020); 2023 Aug; 4(4):e341. PubMed ID: 37576862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications.
    Lee TK; Guan XY; Ma S
    Nat Rev Gastroenterol Hepatol; 2022 Jan; 19(1):26-44. PubMed ID: 34504325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Stem Cells in Hepatocellular Carcinoma: Intrinsic and Extrinsic Molecular Mechanisms in Stemness Regulation.
    Fang X; Yan Q; Liu S; Guan XY
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
    Yadav AK; Desai NS
    Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Interplay Between Cancer Fibroblasts, Mesenchymal Stem Cells, and Cancer Stem Cells in Desmoplastic Cancers.
    Chan TS; Shaked Y; Tsai KK
    Front Oncol; 2019; 9():688. PubMed ID: 31417869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between colorectal CSCs and immune cells in tumorigenesis, and strategies for targeting colorectal CSCs.
    Zhao Q; Zong H; Zhu P; Su C; Tang W; Chen Z; Jin S
    Exp Hematol Oncol; 2024 Jan; 13(1):6. PubMed ID: 38254219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic and Extrinsic Factors Impacting Cancer Stemness and Tumor Progression.
    Ponomarev A; Gilazieva Z; Solovyeva V; Allegrucci C; Rizvanov A
    Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative models of cancer stem cells: The stemness phenotype model, 10 years later.
    Kaushik V; Kulkarni Y; Felix K; Azad N; Iyer AKV; Yakisich JS
    World J Stem Cells; 2021 Jul; 13(7):934-943. PubMed ID: 34367485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and opportunities for cancer stem cell-targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell-dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes.
    Alqarni A; Jasim SA; Altalbawy FMA; Kaur H; Kaur I; Rodriguez-Benites C; Deorari M; Alwaily ER; Al-Ani AM; Redhee AH
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23719. PubMed ID: 38764138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Cancer Stem Cells: Therapeutic Implications and Challenges.
    Shahoumi LA
    Front Oral Health; 2021; 2():685236. PubMed ID: 35048028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Stem Cell Metabolism and Potential Therapeutic Targets.
    Snyder V; Reed-Newman TC; Arnold L; Thomas SM; Anant S
    Front Oncol; 2018; 8():203. PubMed ID: 29922594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
    Walcher L; Kistenmacher AK; Suo H; Kitte R; Dluczek S; Strauß A; Blaudszun AR; Yevsa T; Fricke S; Kossatz-Boehlert U
    Front Immunol; 2020; 11():1280. PubMed ID: 32849491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment.
    Wu B; Shi X; Jiang M; Liu H
    Mol Cancer; 2023 Feb; 22(1):38. PubMed ID: 36810098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer.
    Olivares-Urbano MA; Griñán-Lisón C; Marchal JA; Núñez MI
    Cells; 2020 Jul; 9(7):. PubMed ID: 32660072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Stem Cell Niche in Colorectal Cancer and Targeted Therapies.
    Wang H; Cui G; Yu B; Sun M; Yang H
    Curr Pharm Des; 2020; 26(17):1979-1993. PubMed ID: 32268862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical and therapeutic implications of cancer stem cell biology.
    Cheng L; Alexander R; Zhang S; Pan CX; MacLennan GT; Lopez-Beltran A; Montironi R
    Expert Rev Anticancer Ther; 2011 Jul; 11(7):1131-43. PubMed ID: 21806335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
    Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
    Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.